miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI.

Soheilifar, Mohammad Hasan; Pornour, Majid; Saidijam, Massoud; Najafi, Rezvan; Azizi Jalilian, Farid; Keshmiri Neghab, Hoda; Amini, Razieh

Soheilifar, Mohammad Hasan; Pornour, Majid; Saidijam, Massoud; Najafi, Rezvan; Azizi Jalilian, Farid; Keshmiri Neghab, Hoda; Amini, Razieh.

Afiliación

Soheilifar MH; Research Center for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, 6517838678, Iran.
Pornour M; Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, 1315795613, Iran.
Saidijam M; Research Center for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, 6517838678, Iran.
Najafi R; Research Center for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, 6517838678, Iran.
Azizi Jalilian F; Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, 6517838678, Iran.
Keshmiri Neghab H; Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, 1315795613, Iran.
Amini R; Research Center for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, 6517838678, Iran.

Bioimpacts ; 12(4): 349-358, 2022.

Article en En | MEDLINE | ID: mdl-35975203

Palabras clave

Angiogenesis; DKK3; Oncogenesis; SCAI; THBS1; miR-1290

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Bioimpacts Año: 2022 Tipo del documento: Article País de afiliación: Irán